agilon health (NYSE:AGL) Trading Up 5.7% – Here’s Why

agilon health, inc. (NYSE:AGL) shares rose 5.7% during trading on Monday . The stock traded as high as $2.24 and last traded at $2.21. Approximately 854,352 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 4,907,579 shares. The stock had previously closed at $2.09.

Wall Street Analyst Weigh In

AGL has been the topic of several research analyst reports. Benchmark reissued a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Citigroup reduced their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Evercore ISI reduced their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Finally, JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $6.05.

agilon health Price Performance

The company has a market capitalization of $964.12 million, a PE ratio of -2.36 and a beta of 0.60. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a fifty day simple moving average of $2.73 and a 200-day simple moving average of $4.63.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period last year, the firm earned ($0.06) earnings per share. Equities analysts anticipate that agilon health, inc. will post -0.47 earnings per share for the current year.

Insider Activity

In related news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC increased its position in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC increased its position in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the period. Simplicity Wealth LLC increased its position in agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after purchasing an additional 15,515 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in agilon health during the 2nd quarter worth approximately $1,849,000. Finally, Citigroup Inc. grew its holdings in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.